ImmuCell Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	49	44	36	44	54	35
Market Cap Growth	8.73%	24.20%	-19.28%	-18.81%	55.23%	6.04%
Enterprise Value	58	56	49	48	54	39
Last Close Price	5.60	4.72	4.42	5.65	7.50	5.05
PE Ratio	24.89	-	-	-	-	-
PS Ratio	2.08	1.73	2.26	2.55	3.22	2.80
PB Ratio	1.94	1.67	1.58	1.56	1.90	1.52
P/TBV Ratio	1.95	1.68	1.59	1.56	1.91	1.53
P/FCF Ratio	80.85	-	-	-	-	-
P/OCF Ratio	29.07	128.23	-	-	64.91	32.62
EV/Sales Ratio	2.44	2.17	3.10	2.76	3.22	3.13
EV/EBITDA Ratio	11.43	39.63	-	65.78	22.78	49.62
EV/EBIT Ratio	24.78	-	-	-	240.62	-
EV/FCF Ratio	94.38	-	-	-	-	-
Debt / Equity Ratio	0.46	0.55	0.67	0.41	0.32	0.38
Debt / EBITDA Ratio	2.29	7.75	-	12.96	3.57	9.69
Debt / FCF Ratio	19.02	-	-	-	-	-
Net Debt / Equity Ratio	0.33	0.41	0.63	0.22	0.00	0.10
Net Debt / EBITDA Ratio	1.79	7.80	-6.27	8.60	0.03	2.88
Net Debt / FCF Ratio	13.59	-105.19	-2.39	-1.21	-0.05	-1.01
Asset Turnover	0.62	0.60	0.39	0.42	0.45	0.39
Inventory Turnover	1.85	2.43	1.89	2.26	4.09	3.68
Quick Ratio	1.63	1.72	0.76	2.47	5.09	4.44
Current Ratio	4.21	3.41	2.73	4.56	6.42	5.50
Return on Equity (ROE)	8.27%	-8.21%	-20.86%	-7.92%	-0.26%	-3.57%
Return on Assets (ROA)	3.79%	-1.73%	-7.36%	-2.39%	0.38%	-2.18%
Return on Invested Capital (ROIC)	7.00%	-3.10%	-13.43%	-4.90%	0.81%	-4.62%
Return on Capital Employed (ROCE)	6.60%	-3.00%	-13.20%	-4.10%	0.60%	-3.60%
Earnings Yield	4.02%	-4.70%	-14.64%	-5.28%	-0.13%	-2.38%
FCF Yield	1.24%	-0.24%	-16.64%	-11.68%	-2.67%	-6.42%
Buyback Yield / Dilution	-14.38%	-5.42%	-0.03%	-2.01%	-5.25%	-5.78%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.